Eloralintide, a selective, long‐acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept - Bhattachar - 2026 - Diabetes, Obesity and Metabolism US$ 23.74 Min. order: 1 piece ★★★★★ 4.7 (260 reviews) Sold : Login>>
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines US$ 22.42 Min. order: 1 piece ★★★★★ 4.4 (284 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 27.06 Min. order: 1 piece ★★★★★ 4.3 (254 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 22.49 Min. order: 1 piece ★★★★★ 4.7 (170 reviews) Sold : Login>>
Development of Cagrilintide, a Long-Acting Amylin Analogue US$ 28.69 Min. order: 1 piece ★★★★★ 4.6 (108 reviews) Sold : Login>>